CDEK
← All organizations

Schwarz Pharma

For profitContributed to NME

Also known as: Sanol GmbH | Schwarz BioSciences GmbH | SCHWARZ PHARMA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2002

First marketed drug

Jan 1, 1985

First NDA

May 9, 2007

Last known activity

Mar 1, 2011

Acquired by UCB on Jan 1, 2006

Timeline

1980s

  1. Jan 1, 1985

    Schwarz Pharma— Founded

  2. Jan 25, 1988

    hydrocodone— Marketing Organization

1990s

  1. Jan 1, 1995

    Block Drug— Acquired

  2. Jan 1, 1995

    Central Pharmacal— Acquired

2000s

  1. Jan 1, 2005

    Aderis— Acquired

  2. Jan 1, 2006

    UCB— Acquired By

  3. May 9, 2007

    rotigotine— NDA Organization

Drugs by trial phase (3 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (8)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Mequon, WI, US Jan 1, 1985
First NDA
May 9, 2007
Last known activity
Mar 1, 2011

Notes

Acquired by UCB